Biogen Closes The Book On The Aduhelm Saga

 
• By Jessica Merrill
  
closed book
Biogen is ending development and commercialization of Aduhelm • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Strategy

More from Business